| Financial Year |
March 31 2023 |
| Monetary Funds |
1,000,507,281.05 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
138,132,019.93 |
| Accounts Receivable |
669,037,518.67 |
| Advances to Suppliers |
22,214,583.46 |
| Other Receivables |
156,628,422.56 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
751,047,430.09 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
221,760,535.94 |
| Total Current Assets |
5,190,192,419.92 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
54,969,116.41 |
| Investment Properties |
5,760,405,272.73 |
| Fixed Assetes |
641,629,473.99 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
95,662,471.25 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
9,066,308.87 |
| Deferred Income Tax Assets |
221,787,761.80 |
| Other Non-Current Assets |
484,495,059.05 |
| Sub-Total of Non-Current Assets |
7,307,253,907.47 |
| Total Assets |
12,497,446,327.39 |
| Short-Term Loans |
1,380,984,428.12 |
| Trading Financial liabilities |
-- |
| Notes Payable |
671,038,554.77 |
| Accounts Payable |
1,547,016,360.05 |
| Accounts Received In Advance |
3,529,864.48 |
| Employee Compensation Payable |
31,800,167.78 |
| Taxes Payable |
67,098,503.21 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
111,678,765.61 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
84,610,446.60 |
| Other Current Liabilities |
57,769,963.85 |
| Sub-Total of Current Liabilities |
4,129,304,167.33 |
| Long-term Loans |
1,246,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
201,140,219.18 |
| Special Payable |
-- |
| Estimatied Liabilities |
2,967,290.19 |
| Deferred Income Tax Liabilities |
1,061,561,958.02 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,528,268,943.28 |
| Total Liabilities |
6,657,573,110.61 |
| Paid-In Capital(Or Share Stock) |
1,073,874,227.00 |
| Capital Surplus |
11,459,588.40 |
| Surplus Reserve |
79,324,940.43 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
4,570,423,718.98 |
| Minority Stockholder's Interest |
72,586,412.62 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,767,286,804.16 |
| Owner's Equity（Stockholder's Equity） |
5,839,873,216.78 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
12,497,446,327.39 |
